Conference on protein toxins and their effects on bacteria
2024 Lakeside Conference on Protein Toxins and Effectors
['FUNDING_OTHER'] · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · NIH-11003432
This conference is all about bringing together scientists to learn how harmful bacteria use special proteins to make us sick, and they'll be using cool tools to dig deeper into how these proteins work and affect our cells.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN (nih funded) |
| Locations | 1 site (CHAMPAIGN, UNITED STATES) |
| Trial ID | NIH-11003432 on ClinicalTrials.gov |
What this research studies
This conference focuses on the role of protein toxins and effectors produced by pathogenic bacteria in causing diseases. It aims to bring together researchers to share findings and collaborate on understanding how these toxins disrupt essential functions in target cells. The event will utilize advanced techniques such as CRISPR and cryo-electron microscopy to explore the structure and function of these toxins. By fostering interdisciplinary collaboration, the conference seeks to enhance the dissemination of knowledge in this rapidly evolving field.
Who could benefit from this research
Good fit: Patients suffering from diseases linked to bacterial toxins, such as botulism or cholera, may benefit from the advancements discussed at this conference.
Not a fit: Patients with non-bacterial infections or conditions unrelated to protein toxins may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and potential treatments for diseases caused by bacterial toxins.
How similar studies have performed: Previous conferences and research initiatives focusing on bacterial toxins have successfully advanced the field, indicating a strong potential for impactful outcomes.
Where this research is happening
CHAMPAIGN, UNITED STATES
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN — CHAMPAIGN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BLANKE, STEVEN R. — UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
- Study coordinator: BLANKE, STEVEN R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.